Ruth Mokgokong

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 7

Top Topics

Atrial Fibrillation

Clinical Decision Support

Oral Anticoagulants

Top Venues

Journal of medical economics

Thrombosis and haemostasis

Future oncology (London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Shreeya Patel, Thitima Kongnakorn, Andreas Nikolaou, Yassir Javaid, Ruth Mokgokong
Cost-effectiveness of targeted screening for non-valvular atrial fibrillation in the United Kingdom in older patients using digital approaches. Journal of medical economics 26 (1) (2023)
Laurent Bertoletti, Gaelle Gusto, Nadia Quignot, Artak Khachatryan, Jose Chaves, Audrey Moniot, Ruth Mokgokong, Isabelle Mahe
Low Molecular Weight Heparin Treatment Patterns and Outcomes in Cancer Patients with Acute Venous Thromboembolism: A Nationwide Cohort Study in France. Cancers 15 (11) (2023)
Shreeya Patel, Thitima Kongnakorn, Andreas Nikolaou, Yassir Javaid, Ruth Mokgokong
Cost-effectiveness of targeted screening for non-valvular atrial fibrillation in the United Kingdom in older patients using digital approaches. Journal of medical economics (2023)
Ruth Mokgokong, Artak Khachatryan, Nadia Quignot, Jose Chaves, Audrey Moniot, Gaelle Gusto
Comparative Analysis of All-Cause Health Care Resource Utilization and Costs Among Venous Thrombosis Patients Without Cancer Prescribed Apixaban or VKAs in France. Advances in therapy 39 (8) (2022)
Laurent Bertoletti, Gaelle Gusto, Artak Khachatryan, Nadia Quignot, Jose Chaves, Audrey Moniot, Ruth Mokgokong
Effectiveness and Safety of Oral Anticoagulants in the Treatment of Acute Venous Thromboembolism: A Nationwide Comparative Cohort Study in France. Thrombosis and haemostasis 122 (8) (2022)
Ruth Mokgokong, Renate Schnabel, Henning Witt, Robert Miller, Theodore C Lee
Performance of an electronic health record-based predictive model to identify patients with atrial fibrillation across countries. PloS one 17 (7) (2022)
Bogdan Muresan, Carla M Mamolo, Joseph C Cappelleri, Ruth Mokgokong, Athina Palaka, Fanni Soikkeli, Bart Heeg
Comparing cure rates for gemtuzumab ozogamicin plus standard chemotherapy vs standard chemotherapy alone in acute myeloid leukemia patients. Future oncology (London, England) 17 (22) (2021)